14
I Use This!
Moderate Activity
Analyzed about 16 hours ago. based on code collected 1 day ago.

Project Summary

BioJava is an open-source project dedicated to providing a Java framework for processing biological data. It include objects for manipulating biological sequences, file parsers, DAS client and server support, access to BioSQL and Ensembl databases, tools for making sequence analysis GUIs and powerful analysis and statistical routines including a dynamic programming toolkit.

BioJava is used in several real-world bioinformatics applications and has been used for bioinformatics analysis in a number of published studies.

Tags

bioinformatics bio-informatics biology cross-platform development java research science toolkit

Badges

MIT
Permitted

Commercial Use

Modify

Distribute

Place Warranty

Use Patent Claims

Forbidden

Sub-License

Hold Liable

Required

Distribute Original

Disclose Source

Include Copyright

State Changes

Include License

Include Install Instructions

These details are provided for information only. No information here is legal advice and should not be used as such.

Project Security

Vulnerabilities per Version ( last 10 releases )

There are no reported vulnerabilities

Project Vulnerability Report

Security Confidence Index

Poor security track-record
Favorable security track-record

Vulnerability Exposure Index

Many reported vulnerabilities
Few reported vulnerabilities

Did You Know...

  • ...
    in 2016, 47% of companies did not have formal process in place to track OS code
  • ...
    compare projects before you chose one to use
  • ...
    nearly 1 in 3 companies have no process for identifying, tracking, or remediating known open source vulnerabilities
  • ...
    you can embed statistics from Open Hub on your site
About Project Security

Languages

Languages?height=75&width=75
XML
58%
Java
42%
8 Other
<1%

30 Day Summary

May 18 2021 — Jun 17 2021

12 Month Summary

Jun 17 2020 — Jun 17 2021
  • 180 Commits
    Up + 41 (29%) from previous 12 months
  • 16 Contributors
    Up + 5 (45%) from previous 12 months